Clinical Trial Update: A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial sponsored by GlaxoSmithKline investigating emotional changes in individuals with Social Anxiety Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 1 | Status: COMPLETED